Fortress Biotech Inc. (FBIOP)
6.38
-0.08 (-1.24%)
At close: Mar 27, 2025, 3:46 PM
6.38
0.00%
After-hours: Mar 27, 2025, 04:00 PM EDT
Fortress Biotech Income Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 |
| Revenue | 84.51M | 75.74M | 68.79M | 45.6M | 36.63M | 26.88M | 187.58M | 16.48M | 863K | n/a | n/a | n/a | n/a | n/a |
| Cost of Revenue | 26.66M | 30.77M | 32.08M | 14.59M | 10.53M | 6.13M | 161.2M | 11.35M | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit | 57.85M | 44.97M | 36.71M | 31M | 26.1M | 20.76M | 26.38M | 5.13M | 863K | n/a | n/a | n/a | n/a | n/a |
| Operating Income | -142.34M | -202.26M | -179M | -94.27M | -110.82M | -120M | -101.21M | -65.71M | -50.53M | -20.65M | -35.78M | -27.18M | -35.04M | -9.24M |
| Interest Income | 3M | 1.4M | 649K | 1.52M | 2.56M | 1.1M | 819K | 298K | 245K | 662K | 545K | 236K | 165K | 61K |
| Pretax Income | -153.63M | -213.46M | -164.35M | -102.85M | -101.66M | -130.8M | -98.32M | -71.29M | -53.88M | -20.39M | -37.16M | -27.61M | -36.36M | -9.98M |
| Net Income | -60.64M | -213.91M | -164.83M | -102.98M | -51.81M | -84.15M | -66.88M | -55.09M | -48.43M | -20.39M | -37.16M | -27.61M | -36.36M | -9.98M |
| Selling & General & Admin | 94.12M | 113.66M | 86.84M | 61.17M | 55.59M | 53.37M | 73.02M | 35.16M | 21.58M | 10.41M | 10.1M | 8.66M | 5.75M | 900K |
| Research & Development | 106.07M | 134.88M | 128.87M | 64.11M | 81.33M | 87.38M | 52.49M | 35.13M | 29.81M | 10.24M | 25.68M | 18.51M | 29.29M | 8.34M |
| Other Expenses | n/a | -1.3M | 25.16M | 2.83M | 6.09M | 68K | -234K | -9.87M | 11.41M | n/a | n/a | n/a | 5.75M | 733K |
| Operating Expenses | 200.19M | 247.23M | 215.71M | 125.28M | 136.92M | 140.75M | 127.59M | 70.84M | 51.39M | 20.65M | 35.78M | 27.18M | 35.04M | 9.24M |
| Interest Expense | 11.91M | 13.64M | 15.31M | 9.7M | 11.85M | 10.34M | 5.86M | 3.69M | 1.48M | 1.34M | 1.9M | 670K | 74K | 313K |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | 155.19M | 10.41M | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 226.85M | 278M | 247.79M | 139.87M | 147.45M | 146.88M | 288.79M | 82.19M | 51.39M | 20.65M | 35.78M | 27.18M | 35.04M | 9.24M |
| Income Tax | 521K | 449K | 473K | 136K | -49.85M | -463K | 1.51M | -12.51M | -4M | 1.31M | 525K | 233K | -91K | 1.05M |
| Shares Outstanding (Basic) | 8.11M | 5.92M | 5.45M | 4.8M | 3.65M | 2.9M | 2.78M | 2.66M | 2.61M | 2.42M | 2.03M | 1.44M | 7.66M | 5.9M |
| Shares Outstanding (Diluted) | 8.11M | 5.92M | 5.45M | 4.8M | 3.65M | 2.9M | 2.78M | 2.66M | 2.61M | 2.42M | 2.03M | 1.44M | 7.66M | 5.9M |
| EPS (Basic) | -8.47 | -36.1 | -30.26 | -21.45 | -14.2 | -29.04 | -24.08 | -20.68 | -18.56 | -8.42 | -18.32 | -19.12 | -4.74 | -1.69 |
| EPS (Diluted) | -8.47 | -36.1 | -30.26 | -21.45 | -14.2 | -29.04 | -24.08 | -20.68 | -18.56 | -8.42 | -18.32 | -19.12 | -4.74 | -1.69 |
| EBITDA | -133.64M | -190.47M | -142.25M | -87.82M | -85.16M | -118.4M | -88.57M | -66.87M | -52.37M | -20.63M | -35.76M | -27.18M | -35.04M | -8.45M |
| Depreciation & Amortization | 8.07M | 9.35M | 6.79M | 5.33M | 4.65M | 2.06M | 1.26M | 728K | 26K | 23K | 17K | 3K | 1.41M | 5K |